CASI Pharma Stock Price (NASDAQ:CASI)

Add to My Stocks
$5.74 $0.11 (1.95%) CASI stock closing price Sep 18, 2018 (Closing)
Prev Close* : $5.63
Market Cap:
$487.51M
Day Low: $5.62
52 Week Low: $1.40
Open: $5.62
Volume: -
Day High: $6
52 Week High: $8.89
Dividend:
0.00

Latest Stock Market News

Latest Articles

CASI Stockcharts

View CASI PE ratio, PS ratio stocks charts and compare with peers.
CASI Chart
Note: Compare CASI Pharma stock price history with the index and industry peers.

CASI Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

CASI Pharma Returns

ROE
(return on equity)
-36%

CASI Pharma Financial Ratios

Asset Turnover
0
Receivables Turnover
-
Debt to Equity
0.02
Dividend Yield
-999.0000

CASI Industry Peers

Company Price Change (%)
Chemocentryx (CCXI)11.521.03 (9.82%)
Siga Technologies (SIGA)6.710.07 (1.03%)
Amgen (AMGN)202.341.53 (0.76%)
Rigel Pharma (RIGL)3.520.11 (3.23%)
Tetralogic Pharma (TLOG)0.020 (0%)
Neurocrine Biosciences (NBIX)120.262.9 (2.47%)
Repligen (RGEN)57.420.13 (0.23%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

CASI Pharmaceuticals Inc Stock News - Partner Headlines

2 Stocks Move on Monday   on Apr 02, 2018

CASI Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-10.77M-9.45M-7.2M-26.2M-5.73M
Total Operating Expense10.74M9.41M7.18M26.19M5.73M
View CASI Pharma income statement
balance sheet20172016201520142013
Total Assets45.1M27.71M5.82M11.3M15.5M
Total Liabilities6.56M6.92M11.91M11.73M-
Shareholders Equity38.54M20.78M-6.08M-0.42M14.94M
View CASI Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities3.57M----
Net Cash from (used by) Operating Activities-6.4M-6.02M-5.51M-3.99M-3.27M
Increase (Decrease) in Prop Plant And Equipment-0.93M-0.06M-0.02M-0.23M-0.04M
View CASI Pharma cash flow statement

CASI Pharma Stock Message Board

An investor needs to spend $5.74 to buy CASI stock, as the closing CASI Pharma stock price is $5.74. Stock price or share price can be used to find the total market value of a company. CASI Pharma market cap stands at $487.51M as of Sep 18, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing CASI Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that CASI Pharma is worth a lot, it will most likely be reflected in an inflated CASI Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 295,912 shares were traded with a closing stock price of $5.74 as of Sep 18, 2018, as can be seen from CASI Pharma stock quote. One can view CASI Pharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. CASI Pharma dividend per share was 0.00 during the last quarter. CASI Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.